Live feed
Filing
SC 13G
SC 13G0001395064-22-000018·TAKEDA PHARMACEUTICAL CO LTD
Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Security class unavailable · CUSIP: 98422T100
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,475,121
- Percent of class
- 5.3700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-22-000018
- Form type
- SC 13G
- Filer
- TAKEDA PHARMACEUTICAL CO LTD
- CIK
- CIK 1395064
- Filed
- Jan 14, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership